Andrew Saik

Mr. Andrew R.
Saik is an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. and a Chief Financial Officer & Treasurer at Arvinas, Inc. He is on the Board of Directors at Milestone Pharmaceuticals, Inc. Mr. Saik was previously employed as a Chief Financial Officer by Intercept Pharmaceuticals, Inc., a Chief Financial Officer & Treasurer by Menlo Therapeutics, Inc., a Chief Financial Officer & Treasurer by VYNE Therapeutics, Inc., a Chief Financial Officer & Director by PDS Biotechnology Corp., a Chief Financial Officer by Edge Therapeutics, Inc., a Chief Financial Officer by Vertice Pharma LLC, a Chief Financial Officer by Auxilium Pharmaceuticals LLC, a Treasurer & Senior Vice President-Finance by Endo Health Solutions, Inc., a Senior Vice President-Finance by Valeant Pharmaceuticals International Corp., and a Finance Manager by nexgenIX, Inc. He received his undergraduate degree from the University of California, Los Angeles and an MBA from the University of Southern California.